15-32731469-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_013372.7(GREM1):c.*224C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.559 in 584,906 control chromosomes in the GnomAD database, including 94,911 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.49 ( 20282 hom., cov: 31)
Exomes 𝑓: 0.58 ( 74629 hom. )
Consequence
GREM1
NM_013372.7 3_prime_UTR
NM_013372.7 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.215
Publications
9 publications found
Genes affected
GREM1 (HGNC:2001): (gremlin 1, DAN family BMP antagonist) This gene encodes a member of the BMP (bone morphogenic protein) antagonist family. Like BMPs, BMP antagonists contain cystine knots and typically form homo- and heterodimers. The CAN (cerberus and dan) subfamily of BMP antagonists, to which this gene belongs, is characterized by a C-terminal cystine knot with an eight-membered ring. The antagonistic effect of the secreted glycosylated protein encoded by this gene is likely due to its direct binding to BMP proteins. As an antagonist of BMP, this gene may play a role in regulating organogenesis, body patterning, and tissue differentiation. In mouse, this protein has been shown to relay the sonic hedgehog (SHH) signal from the polarizing region to the apical ectodermal ridge during limb bud outgrowth. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2010]
GREM1 Gene-Disease associations (from GenCC):
- hereditary mixed polyposis syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, G2P
- polyposis syndrome, hereditary mixed, 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 15-32731469-C-T is Benign according to our data. Variant chr15-32731469-C-T is described in ClinVar as Benign. ClinVar VariationId is 1222045.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.748 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GREM1 | NM_013372.7 | c.*224C>T | 3_prime_UTR_variant | Exon 2 of 2 | ENST00000651154.1 | NP_037504.1 | ||
| GREM1 | NM_001368719.1 | c.*224C>T | 3_prime_UTR_variant | Exon 2 of 2 | NP_001355648.1 | |||
| GREM1 | NM_001191323.2 | c.*224C>T | 3_prime_UTR_variant | Exon 3 of 3 | NP_001178252.1 | |||
| GREM1 | NM_001191322.2 | c.*224C>T | 3_prime_UTR_variant | Exon 3 of 3 | NP_001178251.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GREM1 | ENST00000651154.1 | c.*224C>T | 3_prime_UTR_variant | Exon 2 of 2 | NM_013372.7 | ENSP00000498748.1 | ||||
| GREM1 | ENST00000652365.1 | c.*224C>T | 3_prime_UTR_variant | Exon 2 of 2 | ENSP00000498763.1 | |||||
| GREM1 | ENST00000560830.1 | c.*224C>T | 3_prime_UTR_variant | Exon 3 of 3 | 2 | ENSP00000453141.1 | ||||
| GREM1 | ENST00000560677.5 | c.*529C>T | downstream_gene_variant | 4 | ENSP00000453387.1 |
Frequencies
GnomAD3 genomes AF: 0.492 AC: 74616AN: 151798Hom.: 20278 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
74616
AN:
151798
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.582 AC: 252042AN: 432992Hom.: 74629 Cov.: 2 AF XY: 0.585 AC XY: 132065AN XY: 225844 show subpopulations
GnomAD4 exome
AF:
AC:
252042
AN:
432992
Hom.:
Cov.:
2
AF XY:
AC XY:
132065
AN XY:
225844
show subpopulations
African (AFR)
AF:
AC:
2802
AN:
11862
American (AMR)
AF:
AC:
8033
AN:
15552
Ashkenazi Jewish (ASJ)
AF:
AC:
7808
AN:
13212
East Asian (EAS)
AF:
AC:
20856
AN:
29604
South Asian (SAS)
AF:
AC:
23095
AN:
38298
European-Finnish (FIN)
AF:
AC:
26071
AN:
42712
Middle Eastern (MID)
AF:
AC:
1091
AN:
1886
European-Non Finnish (NFE)
AF:
AC:
148130
AN:
255074
Other (OTH)
AF:
AC:
14156
AN:
24792
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
4964
9928
14891
19855
24819
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
704
1408
2112
2816
3520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.491 AC: 74638AN: 151914Hom.: 20282 Cov.: 31 AF XY: 0.498 AC XY: 37004AN XY: 74238 show subpopulations
GnomAD4 genome
AF:
AC:
74638
AN:
151914
Hom.:
Cov.:
31
AF XY:
AC XY:
37004
AN XY:
74238
show subpopulations
African (AFR)
AF:
AC:
10076
AN:
41410
American (AMR)
AF:
AC:
7968
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
AC:
2104
AN:
3472
East Asian (EAS)
AF:
AC:
3938
AN:
5128
South Asian (SAS)
AF:
AC:
2979
AN:
4804
European-Finnish (FIN)
AF:
AC:
6445
AN:
10558
Middle Eastern (MID)
AF:
AC:
170
AN:
294
European-Non Finnish (NFE)
AF:
AC:
39443
AN:
67954
Other (OTH)
AF:
AC:
1099
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1756
3513
5269
7026
8782
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
666
1332
1998
2664
3330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2221
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 06, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.